PLA2R1 and membranous glomerulonephritis: In 2009, autoantibodies against the type-M phospholipase A2 receptor (PLA2R) antigen, mainly consisting of IgG4, were detected in approximately 70% of patients with primary membranous nephropathy, whereas antibodies were not detected in patients with secondary membranous nephropathy or other diseases [11].